Article
Inhibition of pyrimidine biosynthesis targets protein translation in AML
2021-09-24
Abstract excerpt
The mitochondrial enzyme dihydroorotate dehydrogenase (DHODH) catalyzes one of the rate-limiting steps in de novo pyrimidine biosynthesis, a pathway that provides essential metabolic precursors for nucleic acids, glycoproteins and phospholipids. DHODH inhibitors (DHODHi) are clinically used for autoimmune diseases and are emerging as a novel class of anti-cancer agents, especially in acute myeloid leukemia (AML)...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 29670876-89e5-5b0c-bc57-18073ebf3baf
- DOI
- 10.1101/2021.09.24.461627
